Provincial Drug Coverage Chart
As of March 2017
Coverage is under constant review and is subject to change.
Access to a generic equivalent is generally reported to be identical to that of the relevant brand name medication.
|
Type of Listing |
|||||||||
|
Province |
Bisphosphonates |
SERMs |
Teriparatide (PTH) |
Denosumab |
|||||
|
Etidronate |
Alendronate |
Risedronate |
Zoledronic Acid |
Raloxifene |
|||||
| Didrocal®
Generics available |
Fosamax®
Generics available |
Fosavance®
Generics available |
Actonel®
Generics available |
Actonel
DR™ |
Aclasta® | Evista® | Forteo® | Prolia® | |
| BC | Open
Access |
Restricted
Access |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access** |
| AB | Open
Access |
Restricted
Access |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access** |
| SK | Open
Access |
Restricted
Access |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
| MB | Open
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
Not
Accessible |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
| ON | Open
Access |
Open
Access |
Open
Access |
Open
Access |
Open
Access |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
| QC | Open
Access |
Open
Access |
Open
Access |
Open
Access |
Not
Accessible |
Restricted
Access |
Open
Access |
Restricted
Access |
Restricted
Access |
| NB | Open
Access |
Restricted
Access |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
| NS | Restricted
Access* |
Open Access Generics only |
Open
Access |
Open Access Generics only |
Not
Accessible |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
| PEI | Open
Access |
Restricted
Access |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Restricted
Access |
Not
Accessible |
Not
Accessible |
Restricted
Accessible |
| NFLD | Open
Access |
Restricted
Access |
Restricted
Access |
Restricted
Access |
Not
Accessible |
Not
Accessible |
Restricted
Access |
Not
Accessible |
Restricted
Access |
| YT | Open
Access |
Open
Access |
Not
Accessible |
Restricted
Access |
Not
Accessible |
Not
Accessible |
Restricted
Access |
Not
Accessible |
Restricted
Access |
*Etidronate is now Restricted Access as it is not as effective as other options such as alendronate or risedronate.
**Coverage for both women and men who meet the relevant criteria